271 - 280 of 7939 Results
Title
Year
- Predictors of stress resilience in Parkinson’s disease and associations with symptom progression2024OPENTitle: Predictors of stress resilience in Parkinson’s disease and associations with symptom progressionJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00692-4Citation Count: 8
- Mitochondrial import stress and PINK1-mediated mitophagy: the role of the PINK1-TOMM-TIMM23 supercomplex2024RESTRICTEDTitle: Mitochondrial import stress and PINK1-mediated mitophagy: the role of the PINK1-TOMM-TIMM23 supercomplexJournal Name: AutophagyPublisher: Informa UK LimitedVol: 20Issue #: 8Start Page: 1903End Page: 1905Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/15548627.2024.2340399Citation Count: 0
- RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses2024OPENTitle: RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analysesJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 23Issue #: 6Start Page: 603End Page: 614Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/s1474-4422(24)00121-2Best OA location URL: http://www.thelancet.com/article/S1474442224001212/pdfCitation Count: 22
- Transcriptional programs mediating neuronal toxicity and altered glial-neuronal signaling in aDrosophilaknock-in tauopathy model2024OPENTitle: Transcriptional programs mediating neuronal toxicity and altered glial-neuronal signaling in aDrosophilaknock-in tauopathy modelJournal Name: Genome ResearchPublisher: Cold Spring Harbor LaboratoryVol:Issue #:Start Page: gr.278576.123End Page: gr.278576.123Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1101/gr.278576.123Citation Count: 0
-
OPENTitle: Visualizing chaperone-mediated multistep assembly of the human 20S proteasomeJournal Name: Nature Structural & Molecular BiologyPublisher: Springer Science and Business Media LLCVol: 31Issue #: 8Start Page: 1176End Page: 1188Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41594-024-01268-9Best OA location URL: https://www.nature.com/articles/s41594-024-01268-9.pdfCitation Count: 4
- Biological Staging of the Parkinson’s Progression Markers Initiative (PPMI) Cohort Using the Research Neuronal α-synuclein Disease Integrated Staging System (NSD-ISS) (P11-3.009)2024RESTRICTEDTitle: Biological Staging of the Parkinson’s Progression Markers Initiative (PPMI) Cohort Using the Research Neuronal α-synuclein Disease Integrated Staging System (NSD-ISS) (P11-3.009)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 102Issue #: 17_supplement_1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000204771Citation Count: 0
-
OPENTitle: RASP: Optimal Single Puncta Detection in Complex Cellular BackgroundsJournal Name: The Journal of Physical Chemistry BPublisher: American Chemical Society (ACS)Vol: 128Issue #: 15Start Page: 3585End Page: 3597Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/acs.jpcb.4c00174Citation Count: 0
- Rational design of structure‐based vaccines targeting misfolded alpha‐synuclein conformers of Parkinson's disease and related disorders2024OPENTitle: Rational design of structure‐based vaccines targeting misfolded alpha‐synuclein conformers of Parkinson's disease and related disordersJournal Name: Bioengineering & Translational MedicinePublisher: WileyVol: 9Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/btm2.10665Citation Count: 0
- [125I]IPC-Lecanemab: Synthesis and Evaluation of Aβ-Plaque-Binding Antibody and Comparison with Small-Molecule [18F]Flotaza and [125I]IBETA in Postmortem Human Alzheimer’s Disease2024OPENTitle: [125I]IPC-Lecanemab: Synthesis and Evaluation of Aβ-Plaque-Binding Antibody and Comparison with Small-Molecule [18F]Flotaza and [125I]IBETA in Postmortem Human Alzheimer’s DiseaseJournal Name: Neurology InternationalPublisher: MDPI AGVol: 16Issue #: 2Start Page: 419End Page: 431Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/neurolint16020031Citation Count: 3
- Factors Influencing Patient Disclosure of Parkinson's Disease Genetic Testing Results to Relatives2024OPENTitle: Factors Influencing Patient Disclosure of Parkinson's Disease Genetic Testing Results to RelativesJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 7Start Page: 786End Page: 794Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mdc3.14043Citation Count: 0